Data from the RA registry at Hamad Medical Corporation in Qatar shows variability in disease activity scores, with remission rates ranging from 17.5% to 30.3% depending on the scoring method used, highlighting that many patients do not achieve remission despite various treatment regimens, including TNFα inhibitors (23). The gene discussed is TNF; the disease is rheumatoid arthritis.